Multiple Myeloma Side Effects: When Should You Call Your Care Team? | IMS 2026

Beth Faiman, PhD, CNP, of Cleveland Clinic discusses the symptoms myeloma patients often wait too long to report to their care team at IMS 2026 in Glasgow. She explains why fatigue, fever and neuropathy should be reported promptly, since many symptoms are treatable. Viewers will learn why a fever on bispecific therapy means calling right away, how dose changes can help keep patients on effective therapy longer, and simple ways to track and share concerns between visits.

If this video has helped you or a loved one, consider donating to HealthTree. Every donation helps us continue to create free and high-quality blood cancer educational content: https://give.healthtree.org/give/628617/src=htu

For an organized lesson structure, watch on our site here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!

Patients have the key to find cures for cancer. Learn more about HealthTree's services here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.

Timestamps:
0:00 Introduction: Beth Faiman, PhD, CNP, Cleveland Clinic
0:14 Symptoms Patients Often Write Off as "Just Part of the Diagnosis"
0:51 Fever on Bispecific Therapy: Why You Should Call Right Away
1:32 What to Do About a Fever at Night
2:09 CAR-T vs. Bispecifics: Different Recommendations
2:24 Why Patients Hide Side Effects Like Neuropathy
3:01 "I Don't Want to Bother You": Why You Should Still Reach Out
3:38 How to Track Symptoms Between Appointments
4:37 Conclusion: Don't Wait to Share What's Bothering You